HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yutaka Seino Selected Research

Ghrelin

7/2022d-Allulose Inhibits Ghrelin-Responsive, Glucose-Sensitive and Neuropeptide Y Neurons in the Arcuate Nucleus and Central Injection Suppresses Appetite-Associated Food Intake in Mice.
10/2021Onion component, isoalliin, stimulates feeding and activates the arcuate nucleus neuropeptide Y, ghrelin- and Ninjin'yoeito-responsive neurons.
1/2020Ninjin'yoeito Targets Distinct Ca2+ Channels to Activate Ghrelin-Responsive vs. Unresponsive NPY Neurons in the Arcuate Nucleus.
6/2019Ninjin-yoeito activates ghrelin-responsive and unresponsive NPY neurons in the arcuate nucleus and counteracts cisplatin-induced anorexia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yutaka Seino Research Topics

Disease

115Type 2 Diabetes Mellitus (MODY)
12/2023 - 05/2002
29Body Weight (Weight, Body)
12/2023 - 04/2003
28Insulin Resistance
02/2019 - 07/2002
22Diabetes Mellitus
05/2019 - 01/2002
21Hypoglycemia (Reactive Hypoglycemia)
07/2018 - 09/2006
18Obesity
08/2023 - 07/2002
16Hyperglycemia
10/2017 - 01/2002
15Glucose Intolerance
01/2021 - 03/2003
8Weight Gain
08/2023 - 04/2014
8Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2018 - 08/2002
6Heart Failure
12/2023 - 05/2017
6AIDS-Related Complex (ARC)
01/2023 - 06/2019
5Cardiovascular Diseases (Cardiovascular Disease)
03/2023 - 12/2013
5Myocardial Infarction
03/2023 - 05/2017
4Constipation
01/2022 - 10/2011
4Weight Loss (Weight Reduction)
08/2020 - 10/2010
4Diabetes Complications
12/2013 - 09/2008
3Chronic Renal Insufficiency
12/2023 - 02/2013
3Sarcopenia
10/2023 - 06/2015
3Neoplasms (Cancer)
04/2023 - 06/2019
3Stroke (Strokes)
03/2023 - 01/2020
3Nausea
01/2022 - 11/2015
3Anorexia
10/2021 - 06/2019
3Albuminuria
01/2020 - 03/2014
3Hypertension (High Blood Pressure)
10/2016 - 04/2008
3Ketosis
06/2015 - 08/2008
3Diabetic Nephropathies (Diabetic Nephropathy)
03/2014 - 08/2005
3Bone Fractures (Bone Fracture)
12/2013 - 07/2006
2Urinary Tract Infections (Urinary Tract Infection)
04/2023 - 03/2019
2Pneumonia (Pneumonitis)
04/2023 - 12/2020
2Hyperphagia (Overeating)
07/2022 - 01/2022
2Infections
12/2020 - 10/2010
2Pain (Aches)
12/2020 - 12/2018
2Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
03/2019 - 01/2017

Drug/Important Bio-Agent (IBA)

63Glucose (Dextrose)FDA LinkGeneric
12/2023 - 11/2002
35Insulin (Novolin)FDA Link
12/2021 - 01/2002
21Glucagon-Like Peptide 1 (GLP 1)IBA
12/2022 - 02/2008
19Hypoglycemic Agents (Hypoglycemics)IBA
11/2020 - 12/2004
18LiraglutideFDA Link
08/2022 - 01/2011
17IncretinsIBA
05/2017 - 01/2007
16Glucagon-Like Peptide-1 ReceptorIBA
08/2023 - 02/2008
161,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA
01/2020 - 07/2014
14Blood Glucose (Blood Sugar)IBA
08/2023 - 07/2004
12Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
09/2021 - 04/2003
10gastric inhibitory polypeptide receptorIBA
10/2023 - 07/2002
10Glucagon (Glukagon)FDA Link
12/2021 - 11/2008
10Sitagliptin Phosphate (Januvia)FDA Link
01/2021 - 01/2011
9SodiumIBA
12/2023 - 04/2016
9Sodium-Glucose Transporter 2 InhibitorsIBA
10/2023 - 12/2014
9Triglycerides (Triacylglycerol)IBA
01/2018 - 10/2003
9alogliptinIBA
05/2017 - 09/2011
8Dipeptidyl-Peptidase IV InhibitorsIBA
05/2022 - 06/2009
8Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2022 - 05/2011
7LeptinIBA
01/2023 - 02/2004
7Peptides (Polypeptides)IBA
01/2023 - 05/2011
7lixisenatideIBA
12/2021 - 01/2015
7AdiponectinIBA
02/2013 - 10/2005
6empagliflozinIBA
12/2023 - 03/2019
6Sodium-Glucose Transport ProteinsIBA
10/2023 - 07/2014
6LipidsIBA
01/2023 - 03/2005
5semaglutideIBA
08/2023 - 01/2018
5glimepiride (Amarel)FDA LinkGeneric
01/2021 - 10/2011
5Hormones (Hormone)IBA
01/2017 - 02/2004
5C-PeptideIBA
11/2015 - 08/2008
4Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA
10/2023 - 07/2002
4GhrelinIBA
07/2022 - 06/2019
4AutoantibodiesIBA
10/2021 - 07/2003
4LinagliptinIBA
01/2021 - 10/2016
4rGLP-1 proteinIBA
09/2017 - 12/2009
4C-Reactive ProteinIBA
02/2013 - 12/2002
3Pro-Opiomelanocortin (Proopiomelanocortin)IBA
01/2023 - 07/2022
3Neuropeptide YIBA
07/2022 - 01/2020
3ninjin'yoeitoIBA
10/2021 - 06/2019
3Cisplatin (Platino)FDA LinkGeneric
10/2021 - 06/2019
3Proteins (Proteins, Gene)FDA Link
08/2020 - 03/2008
3AlbuminsIBA
01/2020 - 02/2013
3Metformin (Glucophage)FDA LinkGeneric
07/2018 - 12/2012
3Glyburide (Glibenclamide)FDA LinkGeneric
04/2016 - 07/2014
3Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
02/2013 - 10/2005
3Streptozocin (Streptozotocin)FDA Link
09/2011 - 02/2002
3corosolic acidIBA
04/2008 - 07/2004
3Adenosine Triphosphate (ATP)IBA
08/2006 - 12/2004
2Fura-2 (Fura 2)IBA
12/2022 - 06/2019
2psicose (D-psicose)IBA
12/2022 - 07/2022
2dulaglutideIBA
01/2022 - 12/2021
2ipragliflozinIBA
01/2021 - 01/2021
2omega-Chloroacetophenone (Mace)IBA
01/2021 - 01/2020
2Dietary FiberFDA Link
08/2020 - 06/2013
2Fatty Acids (Saturated Fatty Acids)IBA
08/2020 - 08/2014
2CarbohydratesIBA
08/2020 - 01/2017
2Appetite Depressants (Anorectics)IBA
01/2020 - 06/2019
22,4-thiazolidinedione (thiazolidinedione)IBA
07/2018 - 01/2018
2saxagliptinFDA Link
12/2017 - 05/2017
2EnzymesIBA
01/2015 - 09/2014

Therapy/Procedure

29Glycemic Control
09/2021 - 10/2005
27Therapeutics
01/2021 - 03/2003
3Kampo Medicine (Kampo)
10/2021 - 06/2019
3Transplantation
10/2011 - 02/2002
3Islets of Langerhans Transplantation
03/2008 - 09/2006
2Aftercare (After-Treatment)
08/2023 - 05/2018